For the quarter ending 2025-09-30, ORGO made $150,864K in revenue. $14,525K in net income. Net profit margin of 9.63%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Total revenue | 150,864 | 101,005 | 86,693 | 122,289 |
| Write down of capitalized internal-use software costs | - | - | - | 990 |
| Cost of goods sold | - | - | 23,723 | 29,648 |
| Impairment of property and construction (note 8) | - | - | - | 4,711 |
| Gross profit | - | - | 62,970 | 92,640 |
| Cost of goods sold | 36,251 | 27,630 | - | - |
| Selling, general and administrative | 79,743 | 73,810 | 72,509 | 74,239 |
| Research and development | 13,221 | 10,395 | 10,640 | 13,309 |
| Write-down to fair value for asset held for sale | 922 | 1,746 | 6,567 | - |
| Total operating expenses | 130,137 | 113,581 | 89,716 | 95,149 |
| Income (loss) from operations | 20,727 | -12,576 | -26,746 | -2,508 |
| Interest income (expense), net | -415 | -669 | -961 | 358 |
| Other income, net | 18 | 73 | 2 | -11 |
| Total other income (expense), net | 433 | 742 | 963 | -368 |
| Net income (loss) before income taxes | 21,160 | -11,834 | -25,783 | -2,877 |
| Income tax benefit | -407 | -2,442 | -6,940 | 947 |
| Net income (loss) and comprehensive income (loss) | 21,567 | -9,392 | -18,843 | -3,823 |
| Accretion of redeemable convertible preferred stock to redemption value | 140 | 129 | 121 | 103 |
| Cumulative dividend on redeemable convertible preferred stock | 2,734 | 2,681 | 2,627 | 4,385 |
| Undistributed earnings allocated to participating redeemable convertible preferred stock | 4,168 | - | - | - |
| Net income (loss) attributable to common stockholders, basic, total | 14,525 | -12,202 | -21,591 | -234 |
| Basic | 126,881,709 | 126,853,536 | 126,295,642 | -300,674.333 |
| Earnings per share-basic | 0.11 | -0.1 | -0.17 | -0.033 |
| Earnings per share-diluted | 0.11 | -0.1 | -0.17 | -0.033 |
| Weighted-average common shares outstandingdiluted | 130,848,995 | 126,853,536 | 126,295,642 | -751,159 |
Organogenesis Holdings Inc. (ORGO)
Organogenesis Holdings Inc. (ORGO)